<DOC>
	<DOC>NCT01139658</DOC>
	<brief_summary>Observational cohort study on the prevention of venous thromboembolic events after elective orthopaedic surgery for Total Knee Replacement or Total Hip Replacement iin patients treated with PRADAXA to evaluate the efficacy ant safety of Pradaxa in real-life conditions</brief_summary>
	<brief_title>Prevention of Venous Thromboembolic Events After Elective Orthopaedic Surgery in Patients Treated With PRADAXA</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Dabigatran</mesh_term>
	<criteria>Inclusion criteria: 1. Patients treated with Pradaxa undergoing surgery for Total Knee Replacement or Total Hip Replacement 2. Patients 18 years of age or older at the time of recruitment Exclusion criteria: 1. Patients presenting contraindication to prescription of Pradaxa 2. Patients in whom long term Anti vitamin K treatment is indicated</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>